METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin- 13 (IL-13) antibody, or an antigen bindin...

Full description

Saved in:
Bibliographic Details
Main Authors Allan OLSON, Robert PEACH, Gregg TIMONY, Sheila GUJRATHI
Format Patent
LanguageEnglish
Spanish
Published 21.02.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin- 13 (IL-13) antibody, or an antigen binding fragment, thereof. La presente invención se refiere a los métodos para el tratamiento de las enfermedades en las que es perjudicial la actividad de la IL-13, incluyendo la esofagitis eosinofílica (EoE) y el asma, por medio de la administración a un sujeto que necesite dicho tratamiento, de una composición que contiene un anticuerpo contra la interleucina-13 (IL-13), o un fragmento de enlace al antígeno del mismo.
Bibliography:Application Number: MX20180013172